Quick Takeaways
- BOOTHBAY FUND MANAGEMENT, LLC filed SCHEDULE 13G/A for Forte Biosciences, Inc. Common Stock, $0.001 par value per share (FBRX).
- Disclosed ownership: 0.8%.
- Date of event: 30 Jun 2025.
BOOTHBAY FUND MANAGEMENT, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Forte Biosciences, Inc. Common Stock, $0.001 par value per share (FBRX)
- Filing Manager
- BOOTHBAY FUND MANAGEMENT, LLC
- Reporting Manager
- Boothbay Fund Management, LLC
- Symbol
- FBRX
- Shares outstanding
- 6,723,875 shares
- Disclosed Ownership
- 53,791 shares
- Ownership
- 0.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Aug 2025, 14:43:27 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 13 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BOOTHBAY FUND MANAGEMENT, LLC disclosed 0.8% ownership in Forte Biosciences, Inc. Common Stock, $0.001 par value per share (FBRX) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 13 Feb 2025.
- Current filing was accepted on 07 Aug 2025, 14:43.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Boothbay Fund Management, LLC | 0.8% | 53,791 | 0 | 53,791 | Ari Glass | Ari Glass, Managing Member | |
| Ari Glass | 0.8% | 53,791 | 0 | 53,791 | Ari Glass | Individually |